Line 98: | Line 98: | ||
<li><a href="https://2017.igem.org/Team:Dalhousie/Human_Practices">Summary</a></li> | <li><a href="https://2017.igem.org/Team:Dalhousie/Human_Practices">Summary</a></li> | ||
<li><a href="https://2017.igem.org/Team:Dalhousie/HP/Silver">Science Communication</a></li> | <li><a href="https://2017.igem.org/Team:Dalhousie/HP/Silver">Science Communication</a></li> | ||
− | <li><a href="https://2017.igem.org/Team:Dalhousie/HP/Gold_Integrated"> | + | <li><a href="https://2017.igem.org/Team:Dalhousie/HP/Gold_Integrated">Integrated and Gold</a></li> |
<li><a href="https://2017.igem.org/Team:Dalhousie/Engagement">Public Engagement</a></li> | <li><a href="https://2017.igem.org/Team:Dalhousie/Engagement">Public Engagement</a></li> | ||
<li><a href="https://2017.igem.org/Team:Dalhousie/SocialMedia">Social Media</a></li> | <li><a href="https://2017.igem.org/Team:Dalhousie/SocialMedia">Social Media</a></li> |
Revision as of 03:32, 27 October 2017
Parts
Protocol | Page |
---|---|
Alpha-L-Arabinofuranosidase | BBa_K2331000 |
Endoxylanase | BBa_K2331001 |
Beta-glucosidase | BBa_K2331002 |
Beta-Xylanase | BBa_K2331003 |
Periplasmic-Localizing Endoglucanase | BBa_K2331004 |
Learn more... hopefully have links to next pages here